{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:52:33Z","timestamp":1773064353673,"version":"3.50.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["14370471"],"award-info":[{"award-number":["14370471"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18591156"],"award-info":[{"award-number":["18591156"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20591224"],"award-info":[{"award-number":["20591224"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["SPRING (JPMJSP2146)"],"award-info":[{"award-number":["SPRING (JPMJSP2146)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01694-7","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:21:38Z","timestamp":1747966898000},"page":"1009-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Amyloid neuropathy, tauopathy, decreased cholinergic and dopaminergic neurons, long-term memory and motor deficits, and sleep disturbance in motopsin deficient mice"],"prefix":"10.1007","volume":"48","author":[{"given":"Fumiaki","family":"Yokoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuna","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-151X","authenticated-orcid":false,"given":"Shinichi","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"1694_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/bbrc.1997.7417","volume":"239","author":"Y Yamamura","year":"1997","unstructured":"Yamamura Y, et al. Molecular cloning of a novel brain-specific serine protease with a kringle-like structure and three scavenger receptor cysteine-rich motifs. Biochem Biophys Res Commun. 1997;239:386\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"1694_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1006\/mcne.1997.0616","volume":"9","author":"TP Gschwend","year":"1997","unstructured":"Gschwend TP, Krueger SR, Kozlov SV, Wolfer DP, Sonderegger P. Neurotrypsin, a novel multidomain serine protease expressed in the nervous system. Mol Cell Neurosci. 1997;9:207\u201319.","journal-title":"Mol Cell Neurosci"},{"key":"1694_CR3","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1021\/cr000033x","volume":"102","author":"L Hedstrom","year":"2002","unstructured":"Hedstrom L. Serine protease mechanism and specificity. Chem Rev. 2002;102:4501\u201324.","journal-title":"Chem Rev"},{"key":"1694_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2741\/2818","volume":"13","author":"S Mitsui","year":"2008","unstructured":"Mitsui S, Watanabe Y, Yamaguchi T, Yamaguchi N. Mosaic serine proteases in the mammalian central nervous system. Front Biosci. 2008;13:1991\u20132000.","journal-title":"Front Biosci"},{"key":"1694_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1126\/science.1076521","volume":"298","author":"F Molinari","year":"2002","unstructured":"Molinari F, et al. Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science. 2002;298:1779\u201381.","journal-title":"Science"},{"key":"1694_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0169-328X(99)00008-X","volume":"66","author":"N Iijima","year":"1999","unstructured":"Iijima N, et al. Expression of a serine protease (motopsin PRSS12) mRNA in the mouse brain: in situ hybridization histochemical study. Brain Res Mol Brain Res. 1999;66:141\u20139.","journal-title":"Brain Res Mol Brain Res"},{"key":"1694_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.094","volume":"1136","author":"S Mitsui","year":"2007","unstructured":"Mitsui S, Yamaguchi N, Osako Y, Yuri K. Enzymatic properties and localization of motopsin (PRSS12), a protease whose absence causes mental retardation. Brain Res. 2007;1136:1\u201312.","journal-title":"Brain Res"},{"key":"1694_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bjps.2005.04.018","volume":"59","author":"T Numajiri","year":"2006","unstructured":"Numajiri T, et al. The expression of a motoneuron-specific serine protease, motopsin (PRSS12), after facial nerve axotomy in mice. J Plast Reconstr Aesthet Surg. 2006;59:393\u20137.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"1694_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cbin.10164","volume":"38","author":"S Mitsui","year":"2014","unstructured":"Mitsui S, Osako Y, Yuri K. Mental retardation-related protease, motopsin (prss12), binds to the BRICHOS domain of the integral membrane protein 2a. Cell Biol Int. 2014;38:117\u201323.","journal-title":"Cell Biol Int"},{"key":"1694_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bbrc.2013.04.112","volume":"436","author":"S Mitsui","year":"2013","unstructured":"Mitsui S, Hidaka C, Furihata M, Osako Y, Yuri K. A mental retardation gene, motopsin\/prss12, modulates cell morphology by interaction with seizure-related gene 6. Biochem Biophys Res Commun. 2013;436:638\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"1694_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbrc.2015.04.139","volume":"462","author":"C Hidaka","year":"2015","unstructured":"Hidaka C, Mitsui S. N-Glycosylation modulates filopodia-like protrusions induced by sez-6 through regulating the distribution of this protein on the cell surface. Biochem Biophys Res Commun. 2015;462:346\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"1694_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.cell.2009.02.034","volume":"136","author":"K Matsumoto-Miyai","year":"2009","unstructured":"Matsumoto-Miyai K, et al. Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell. 2009;136:1161\u201371.","journal-title":"Cell"},{"key":"1694_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/BJ20130166","volume":"453","author":"C Gisler","year":"2013","unstructured":"Gisler C, et al. Zymogen activation of neurotrypsin and neurotrypsin-dependent agrin cleavage on the cell surface are enhanced by glycosaminoglycans. Biochem J. 2013;453:83\u2013100.","journal-title":"Biochem J"},{"key":"1694_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1096\/fj.07-100008","volume":"22","author":"A Stephan","year":"2008","unstructured":"Stephan A, et al. Neurotrypsin cleaves agrin locally at the synapse. Faseb J. 2008;22:1861\u201373.","journal-title":"Faseb J"},{"key":"1694_CR15","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1096\/fj.07-8800com","volume":"21","author":"R Reif","year":"2007","unstructured":"Reif R, et al. Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. Faseb j. 2007;21:3468\u201378.","journal-title":"Faseb j"},{"key":"1694_CR16","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1111\/j.1460-9568.2009.07029.x","volume":"30","author":"S Mitsui","year":"2009","unstructured":"Mitsui S, et al. A mental retardation gene, motopsin\/neurotrypsin\/prss12, modulates hippocampal function and social interaction. Eur J Neurosci. 2009;30:2368\u201378.","journal-title":"Eur J Neurosci"},{"key":"1694_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#","volume":"208","author":"AJ Barber","year":"1997","unstructured":"Barber AJ, Lieth E. Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. Dev Dyn. 1997;208:62\u201374.","journal-title":"Dev Dyn"},{"key":"1694_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.neuint.2012.02.028","volume":"61","author":"MP Daniels","year":"2012","unstructured":"Daniels MP. The role of agrin in synaptic development, plasticity and signaling in the central nervous system. Neurochem Int. 2012;61:848\u201353.","journal-title":"Neurochem Int"},{"key":"1694_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/neu.10213","volume":"55","author":"MJ Kim","year":"2003","unstructured":"Kim MJ, Cotman SL, Halfter W, Cole GJ. The heparan sulfate proteoglycan agrin modulates neurite outgrowth mediated by FGF-2. J Neurobiol. 2003;55:261\u201377.","journal-title":"J Neurobiol"},{"key":"1694_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tibs.2010.05.004","volume":"35","author":"H Tidow","year":"2010","unstructured":"Tidow H, Aperia A, Nissen P. How are ion pumps and agrin signaling integrated? Trends Biochem Sci. 2010;35:653\u20139.","journal-title":"Trends Biochem Sci"},{"key":"1694_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.59566\/IJBS.2014.10085","volume":"10","author":"GR de Lores Arnaiz","year":"2014","unstructured":"de Lores Arnaiz GR, Ordieres MG. Brain Na(+), K(+)-ATPase activity in aging and disease. Int J Biomed Sci. 2014;10:85\u2013102.","journal-title":"Int J Biomed Sci"},{"key":"1694_CR22","doi-asserted-by":"publisher","first-page":"16956","DOI":"10.1074\/jbc.M806855200","volume":"284","author":"LGW Hilgenberg","year":"2009","unstructured":"Hilgenberg LGW, et al. Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. J Biol Chem. 2009;284:16956\u201365.","journal-title":"J Biol Chem"},{"key":"1694_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1601-183X.2012.00800.x","volume":"11","author":"GS Kirshenbaum","year":"2012","unstructured":"Kirshenbaum GS, et al. Genetic suppression of agrin reduces mania-like behavior in Na+, K+ -ATPase alpha3 mutant mice. Genes Brain Behav. 2012;11:436\u201343.","journal-title":"Genes Brain Behav"},{"key":"1694_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.WCB.0000039287.37737.50","volume":"23","author":"WB Veldhuis","year":"2003","unstructured":"Veldhuis WB, et al. In vivo excitotoxicity induced by ouabain, a Na+\/K+-ATPase inhibitor. J Cereb Blood Flow Metab. 2003;23:62\u201374.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1694_CR25","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0002-9440(10)65529-0","volume":"155","author":"MM Verbeek","year":"1999","unstructured":"Verbeek MM, et al. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer\u2019s disease brain. Am J Pathol. 1999;155:2115\u201325.","journal-title":"Am J Pathol"},{"key":"1694_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12860-022-00462-1","volume":"23","author":"A Ferreira","year":"2022","unstructured":"Ferreira A, et al. The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates. BMC Mol Cell Biol. 2022;23:61.","journal-title":"BMC Mol Cell Biol"},{"key":"1694_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C. Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener. 2021;16:59.","journal-title":"Mol Neurodegener"},{"key":"1694_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/mcne.1999.0816","volume":"15","author":"SL Cotman","year":"2000","unstructured":"Cotman SL, Halfter W, Cole GJ. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer\u2019s disease brain. Mol Cell Neurosci. 2000;15:183\u201398.","journal-title":"Mol Cell Neurosci"},{"key":"1694_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/NEN.0b013e31823b0b12","volume":"70","author":"SM Rauch","year":"2011","unstructured":"Rauch SM, et al. Changes in brain beta-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice. J Neuropathol Exp Neurol. 2011;70:1124\u201337.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1694_CR30","doi-asserted-by":"publisher","first-page":"P294","DOI":"10.1093\/geronb\/53B.5.P294","volume":"53","author":"RG Logsdon","year":"1998","unstructured":"Logsdon RG, et al. Wandering: a significant problem among community-residing individuals with Alzheimer\u2019s disease. J Gerontol B Psychol Sci Soc Sci. 1998;53:P294-299.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"1694_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neubiorev.2018.09.027","volume":"97","author":"R Winsky-Sommerer","year":"2019","unstructured":"Winsky-Sommerer R, et al. Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer\u2019s disease and schizophrenia: Insights from studies in patient populations and animal models. Neurosci Biobehav Rev. 2019;97:112\u201337.","journal-title":"Neurosci Biobehav Rev"},{"key":"1694_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.neurobiolaging.2009.04.008","volume":"32","author":"ER Rosario","year":"2011","unstructured":"Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer\u2019s disease. Neurobiol Aging. 2011;32:604\u201313.","journal-title":"Neurobiol Aging"},{"key":"1694_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/oxfordjournals.aje.a117244","volume":"140","author":"A Paganini-Hill","year":"1994","unstructured":"Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer\u2019s disease in women. Am J Epidemiol. 1994;140:256\u201361.","journal-title":"Am J Epidemiol"},{"key":"1694_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","volume":"160","author":"BC Riedel","year":"2016","unstructured":"Riedel BC, Thompson PM, Brinton RD. Age, APOE and sex: triad of risk of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol. 2016;160:134\u201347.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1694_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1694_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","volume":"117","author":"AM Fjell","year":"2014","unstructured":"Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB. What is normal in normal aging? Effects of aging, amyloid and Alzheimer\u2019s disease on the cerebral cortex and the hippocampus. Prog Neurobiol. 2014;117:20\u201340.","journal-title":"Prog Neurobiol"},{"key":"1694_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cell.2017.07.004","volume":"170","author":"M Szaruga","year":"2017","unstructured":"Szaruga M, et al. Alzheimer\u2019s-causing mutations shift abeta length by destabilizing gamma-secretase-abetan interactions. Cell. 2017;170:443-456.e414.","journal-title":"Cell"},{"key":"1694_CR38","doi-asserted-by":"publisher","first-page":"27738","DOI":"10.1038\/srep27738","volume":"6","author":"IY Petrushanko","year":"2016","unstructured":"Petrushanko IY, et al. Direct interaction of beta-amyloid with Na, K-ATPase as a putative regulator of the enzyme function. Sci Rep. 2016;6:27738.","journal-title":"Sci Rep"},{"key":"1694_CR39","doi-asserted-by":"publisher","first-page":"E4465","DOI":"10.1073\/pnas.1421182112","volume":"112","author":"T Ohnishi","year":"2015","unstructured":"Ohnishi T, et al. Na, K-ATPase alpha3 is a death target of Alzheimer patient amyloid-beta assembly. Proc Natl Acad Sci U S A. 2015;112:E4465-4474.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR40","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow EM. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci. 2010;30:11938\u201350.","journal-title":"J Neurosci"},{"key":"1694_CR41","doi-asserted-by":"publisher","first-page":"eadd6696","DOI":"10.1126\/science.add6696","volume":"381","author":"ZY Zhang","year":"2023","unstructured":"Zhang ZY, et al. TRIM11 protects against tauopathies and is down-regulated in Alzheimer\u2019s disease. Science. 2023;381:eadd6696.","journal-title":"Science"},{"key":"1694_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG. A century of Alzheimer\u2019s disease. Science. 2006;314:777\u201381.","journal-title":"Science"},{"key":"1694_CR43","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.neurobiolaging.2012.10.018","volume":"34","author":"M Grothe","year":"2013","unstructured":"Grothe M, Heinsen H, Teipel S. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:1210\u201320.","journal-title":"Neurobiol Aging"},{"key":"1694_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15:135\u201347.","journal-title":"Nat Rev Neurol"},{"key":"1694_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","volume":"16","author":"FK Wiseman","year":"2015","unstructured":"Wiseman FK, et al. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci. 2015;16:564\u201374.","journal-title":"Nat Rev Neurosci"},{"key":"1694_CR46","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82:4245\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR47","first-page":"124","volume":"3","author":"F Fernandez","year":"2013","unstructured":"Fernandez F, Edgin JO. Poor sleep as a precursor to cognitive decline in down syndrome\u202f: a hypothesis. J Alzheimers Dis Parkinsonism. 2013;3:124.","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"1694_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clinbiochem.2019.08.005","volume":"73","author":"R Matej","year":"2019","unstructured":"Matej R, Tesar A, Rusina R. Alzheimer\u2019s disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview. Clin Biochem. 2019;73:26\u201331.","journal-title":"Clin Biochem"},{"key":"1694_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jns.2010.08.039","volume":"299","author":"I Ferrer","year":"2010","unstructured":"Ferrer I. Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin. J Neurol Sci. 2010;299:139\u201349.","journal-title":"J Neurol Sci"},{"key":"1694_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000105126","volume":"24","author":"PL Sheridan","year":"2007","unstructured":"Sheridan PL, Hausdorff JM. The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2007;24:125\u201337.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1694_CR51","doi-asserted-by":"crossref","unstructured":"Horvath J, Burkhard PR, Herrmann ER, Bouras C, K\u00f6vari EJ. Neuropathology of Parkinsonism in patients with pure Alzheimer's disease. Alzheimers Dis. 2014;39:115\u201320.","DOI":"10.3233\/JAD-131289"},{"key":"1694_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/jnnp.50.3.341","volume":"50","author":"DM Mann","year":"1987","unstructured":"Mann DM, Yates PO, Marcyniuk B. Dopaminergic neurotransmitter systems in Alzheimer\u2019s disease and in Down\u2019s syndrome at middle age. J Neurol Neurosurg Psychiatry. 1987;50:341\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1694_CR53","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/glycob\/cwj014","volume":"15","author":"IH Liu","year":"2005","unstructured":"Liu IH, et al. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation. Glycobiology. 2005;15:1320\u201331.","journal-title":"Glycobiology"},{"key":"1694_CR54","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.15252\/embj.201591397","volume":"34","author":"AN Shrivastava","year":"2015","unstructured":"Shrivastava AN, et al. \u03b1-synuclein assemblies sequester neuronal \u03b13-Na+\/K+-ATPase and impair Na+ gradient. EMBO J. 2015;34:2408\u201323.","journal-title":"EMBO J"},{"key":"1694_CR55","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.15252\/embj.201592770","volume":"34","author":"PJ Kahle","year":"2015","unstructured":"Kahle PJ, Sugeno N, Skodras A. \u03b1-Synuclein oligomers pump it up! EMBO J. 2015;34:2385\u20137.","journal-title":"EMBO J"},{"key":"1694_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-140491","volume":"5","author":"HE Allen Reish","year":"2015","unstructured":"Allen Reish HE, Standaert DG. Role of \u03b1-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis. 2015;5:1\u201319.","journal-title":"J Parkinsons Dis"},{"key":"1694_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2010.01.001","volume":"1319","author":"L Rochester","year":"2010","unstructured":"Rochester L, et al. Evidence for motor learning in Parkinson\u2019s disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues. Brain Res. 2010;1319:103\u201311.","journal-title":"Brain Res"},{"key":"1694_CR58","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/JPD-191627","volume":"9","author":"NI Bohnen","year":"2019","unstructured":"Bohnen NI, Hu MTM. Sleep disturbance as potential risk and progression factor for Parkinson\u2019s disease. J Parkinsons Dis. 2019;9:603\u201314.","journal-title":"J Parkinsons Dis"},{"key":"1694_CR59","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.chest.2020.09.099","volume":"159","author":"AC Lajoie","year":"2021","unstructured":"Lajoie AC, Lafontaine AL, Kaminska M. The spectrum of sleep disorders in Parkinson disease: a review. Chest. 2021;159:818\u201327.","journal-title":"Chest"},{"key":"1694_CR60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41582-019-0294-x","volume":"16","author":"S Meoni","year":"2020","unstructured":"Meoni S, Macerollo A, Moro E. Sex differences in movement disorders. Nat Rev Neurol. 2020;16:84\u201396.","journal-title":"Nat Rev Neurol"},{"key":"1694_CR61","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan F, et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87:952\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1694_CR62","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41583-020-0313-3","volume":"21","author":"B Voelkl","year":"2020","unstructured":"Voelkl B, et al. Reproducibility of animal research in light of biological variation. Nat Rev Neurosci. 2020;21:384\u201393.","journal-title":"Nat Rev Neurosci"},{"key":"1694_CR63","unstructured":"Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates, 3rd. Elsevier Inc., San Diego"},{"key":"1694_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, et al. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16:30\u201342.","journal-title":"Nat Rev Neurol"},{"key":"1694_CR65","first-page":"230","volume":"57","author":"T Kitamoto","year":"1987","unstructured":"Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest. 1987;57:230\u20136.","journal-title":"Lab Invest"},{"key":"1694_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF00227819","volume":"84","author":"M Mercken","year":"1992","unstructured":"Mercken M, et al. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. 1992;84:265\u201372.","journal-title":"Acta Neuropathol"},{"key":"1694_CR67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett. 1995;189:167\u20139.","journal-title":"Neurosci Lett"},{"key":"1694_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-024-02729-7","volume":"147","author":"MJ Ellis","year":"2024","unstructured":"Ellis MJ, et al. Identification of high-performing antibodies for the reliable detection of Tau proteoforms by western blotting and immunohistochemistry. Acta Neuropathol. 2024;147:87.","journal-title":"Acta Neuropathol"},{"key":"1694_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ibneur.2021.05.003","volume":"11","author":"F Yokoi","year":"2021","unstructured":"Yokoi F, et al. Reversal of motor-skill transfer impairment by trihexyphenidyl and reduction of dorsolateral striatal cholinergic interneurons in Dyt1 \u0394GAG knock-in mice. IBRO Neurosci Rep. 2021;11:1\u20137.","journal-title":"IBRO Neurosci Rep"},{"key":"1694_CR70","doi-asserted-by":"publisher","first-page":"e08352","DOI":"10.7554\/eLife.08352","volume":"4","author":"SS Pappas","year":"2015","unstructured":"Pappas SS, et al. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons. Elife. 2015;4:e08352.","journal-title":"Elife"},{"key":"1694_CR71","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1007\/s12035-023-03890-y","volume":"61","author":"S Miyata","year":"2024","unstructured":"Miyata S, Tsuda M, Mitsui S. Overexpression of motopsin, an extracellular serine protease related to intellectual disability, promotes adult neurogenesis and neuronal responsiveness in the dentate gyrus. Mol Neurobiol. 2024;61:4929\u201348.","journal-title":"Mol Neurobiol"},{"key":"1694_CR72","doi-asserted-by":"publisher","first-page":"9447","DOI":"10.1073\/pnas.0903964106","volume":"106","author":"DP Stefanko","year":"2009","unstructured":"Stefanko DP, Barrett RM, Ly AR, Reolon GK, Wood MA. Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci U S A. 2009;106:9447\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR73","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.npp.1301256","volume":"32","author":"Nagoya University Graduate School of Medicine","year":"2007","unstructured":"Wang D, et al., The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice. Neuropsychopharmacology. 2007;32:1261\u201371.","journal-title":"Neuropsychopharmacology"},{"key":"1694_CR74","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.expneurol.2005.08.025","volume":"196","author":"MT Dang","year":"2005","unstructured":"Dang MT, et al. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol. 2005;196:452\u201363.","journal-title":"Exp Neurol"},{"key":"1694_CR75","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2013.02.066","volume":"543","author":"S Ayton","year":"2013","unstructured":"Ayton S, et al. The effect of dopamine on MPTP-induced rotarod disability. Neurosci Lett. 2013;543:105\u20139.","journal-title":"Neurosci Lett"},{"key":"1694_CR76","volume-title":"in R foundation for statistical computing","author":"R. C. Team","year":"2022","unstructured":"R. C. Team. in R foundation for statistical computing. Vienna: Austria; 2022."},{"key":"1694_CR77","first-page":"378","volume":"9","author":"ME Brooks","year":"2017","unstructured":"Brooks ME, et al. glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling. R Journal. 2017;9:378\u2013400.","journal-title":"R Journal"},{"key":"1694_CR78","doi-asserted-by":"crossref","unstructured":"Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York: Springer; 2000.","DOI":"10.1007\/978-1-4419-0318-1"},{"key":"1694_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v058.i03","volume":"58","author":"R Killick","year":"2014","unstructured":"Killick R, Eckley IA. changepoint: an R package for changepoint analysis. J Stat Softw. 2014;58:1\u201319.","journal-title":"J Stat Softw"},{"key":"1694_CR80","doi-asserted-by":"crossref","unstructured":"Venables WN, Ripley BD. Modern applied statistics with S. Springer, ed. 4th edn, 2002.","DOI":"10.1007\/978-0-387-21706-2"},{"key":"1694_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13041-016-0191-9","volume":"9","author":"H Shoji","year":"2016","unstructured":"Shoji H, Takao K, Hattori S, Miyakawa T. Age-related changes in behavior in C57BL\/6J mice from young adulthood to middle age. Mol Brain. 2016;9:11.","journal-title":"Mol Brain"},{"key":"1694_CR82","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716\u201323.","journal-title":"IEEE Trans Autom Control"},{"key":"1694_CR83","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.csda.2013.09.016","volume":"70","author":"Y Marhuenda","year":"2014","unstructured":"Marhuenda Y, Morales D, Pardo MDC. Information criteria for Fay-Herriot model selection. Comput Stat Data Anal. 2014;70:268\u201380.","journal-title":"Comput Stat Data Anal"},{"key":"1694_CR84","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","volume":"34","author":"SR Searle","year":"1980","unstructured":"Searle SR, Speed FM, Milliken GA. Population marginal means in the linear model: an alternative to least squares means. Am Stat. 1980;34:216\u201321.","journal-title":"Am Stat"},{"key":"1694_CR85","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"1694_CR86","doi-asserted-by":"crossref","unstructured":"Frid P, Anisimov SV, Popovic N. Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev. 2007;53:135\u2013160.","DOI":"10.1016\/j.brainresrev.2006.08.001"},{"key":"1694_CR87","doi-asserted-by":"publisher","first-page":"7589","DOI":"10.1039\/D0CC01161D","volume":"56","author":"B Frieg","year":"2020","unstructured":"Frieg B, Gremer L, Heise H, Willbold D, Gohlke H. Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-\u03b2(1\u201342). Chem Commun (Camb). 2020;56:7589\u201392.","journal-title":"Chem Commun (Camb)"},{"key":"1694_CR88","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","volume":"12","author":"JL Jankowsky","year":"2017","unstructured":"Jankowsky JL, Zheng H. Practical considerations for choosing a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2017;12:89.","journal-title":"Mol Neurodegener"},{"key":"1694_CR89","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0896-6273(00)80085-9","volume":"16","author":"KD Beck","year":"1996","unstructured":"Beck KD, et al. GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron. 1996;16:665\u201373.","journal-title":"Neuron"},{"key":"1694_CR90","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2005.05.002","volume":"46","author":"JE Lisman","year":"2005","unstructured":"Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron. 2005;46:703\u201313.","journal-title":"Neuron"},{"key":"1694_CR91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fnmol.2019.00123","volume":"12","author":"P Krashia","year":"2019","unstructured":"Krashia P, Nobili A, D\u2019Amelio M. Unifying hypothesis of dopamine neuron loss in neurodegenerative diseases: focusing on Alzheimer\u2019s disease. Front Mol Neurosci. 2019;12:123.","journal-title":"Front Mol Neurosci"},{"key":"1694_CR92","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000368279","volume":"93","author":"S Salgado","year":"2015","unstructured":"Salgado S, Kaplitt MG. The nucleus accumbens: a comprehensive review. Stereotact Funct Neurosurg. 2015;93:75\u201393.","journal-title":"Stereotact Funct Neurosurg"},{"key":"1694_CR93","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00441-017-2745-2","volume":"373","author":"C M\u00fcller","year":"2018","unstructured":"M\u00fcller C, Remy S. Septo-hippocampal interaction. Cell Tissue Res. 2018;373:565\u201375.","journal-title":"Cell Tissue Res"},{"key":"1694_CR94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0006-8993(94)91533-4","volume":"633","author":"K Sakai","year":"1994","unstructured":"Sakai K, Gash DM. Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat. Brain Res. 1994;633:144\u201350.","journal-title":"Brain Res"},{"key":"1694_CR95","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","volume":"24","author":"T Ishihara","year":"1999","unstructured":"Ishihara T, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron. 1999;24:751\u201362.","journal-title":"Neuron"},{"key":"1694_CR96","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"1694_CR97","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","volume":"34","author":"SH Xin","year":"2018","unstructured":"Xin SH, Tan L, Cao X, Yu JT. Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res. 2018;34:733\u201348.","journal-title":"Neurotox Res"},{"key":"1694_CR98","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","volume":"138","author":"J Gratwicke","year":"2015","unstructured":"Gratwicke J, Jahanshahi M, Foltynie T. Parkinson\u2019s disease dementia: a neural networks perspective. Brain. 2015;138:1454\u201376.","journal-title":"Brain"},{"key":"1694_CR99","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1365-2990.2010.01091.x","volume":"36","author":"NM Timmer","year":"2010","unstructured":"Timmer NM, et al. Limited expression of heparan sulphate proteoglycans associated with A\u03b2 deposits in the APPswe\/PS1dE9 mouse model for Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2010;36:478\u201386.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1694_CR100","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0006-291X(87)90419-0","volume":"149","author":"T Yamada","year":"1987","unstructured":"Yamada T, et al. Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun. 1987;149:665\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"1694_CR101","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00401-021-02397-x","volume":"143","author":"A Kapasi","year":"2022","unstructured":"Kapasi A, et al. Association of small vessel disease with tau pathology. Acta Neuropathol. 2022;143:349\u201362.","journal-title":"Acta Neuropathol"},{"key":"1694_CR102","doi-asserted-by":"crossref","unstructured":"Braak H, Del Tredici K. Potential pathways of abnormal tau and \u03b1-synuclein dissemination in sporadic Alzheimer\u2019s and Parkinson\u2019s diseases. Cold Spring Harb Perspect Biol. 2016;8: a023630.","DOI":"10.1101\/cshperspect.a023630"},{"key":"1694_CR103","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14336\/AD.2017.0112","volume":"8","author":"DL Castillo-Carranza","year":"2017","unstructured":"Castillo-Carranza DL, et al. Cerebral Microvascular accumulation of tau oligomers in Alzheimer\u2019s disease and related tauopathies. Aging Dis. 2017;8:257\u201366.","journal-title":"Aging Dis"},{"key":"1694_CR104","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1017\/S0317167100035721","volume":"13","author":"C Ezrin-Waters","year":"1986","unstructured":"Ezrin-Waters C, Resch L. The nucleus basalis of Meynert. Can J Neurol Sci. 1986;13:8\u201314.","journal-title":"Can J Neurol Sci"},{"key":"1694_CR105","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221:555\u201363.","journal-title":"Behav Brain Res"},{"key":"1694_CR106","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nbd.2010.10.002","volume":"41","author":"SE Perez","year":"2011","unstructured":"Perez SE, et al. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis. 2011;41:338\u201352.","journal-title":"Neurobiol Dis"},{"key":"1694_CR107","doi-asserted-by":"publisher","first-page":"9231","DOI":"10.1073\/pnas.83.23.9231","volume":"83","author":"LR Williams","year":"1986","unstructured":"Williams LR, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A. 1986;83:9231\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2018.03.002","volume":"67","author":"S Allard","year":"2018","unstructured":"Allard S, Jacobs ML, Do Carmo S, Cuello AC. Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons. Neurobiol Aging. 2018;67:10\u201320.","journal-title":"Neurobiol Aging."},{"key":"1694_CR109","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnins.2019.00062","volume":"13","author":"AC Cuello","year":"2019","unstructured":"Cuello AC, Pentz R, Hall H. The brain NGF metabolic pathway in health and in Alzheimer\u2019s pathology. Front Neurosci. 2019;13:62.","journal-title":"Front Neurosci"},{"key":"1694_CR110","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fnins.2019.00533","volume":"13","author":"EJ Mufson","year":"2019","unstructured":"Mufson EJ, et al. Nerve growth factor pathobiology during the progression of Alzheimer\u2019s disease. Front Neurosci. 2019;13:533.","journal-title":"Front Neurosci"},{"key":"1694_CR111","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cell.2006.01.052","volume":"125","author":"LG Hilgenberg","year":"2006","unstructured":"Hilgenberg LG, Su H, Gu H, O\u2019Dowd DK, Smith MA. Alpha3Na+\/K+-ATPase is a neuronal receptor for agrin. Cell. 2006;125:359\u201369.","journal-title":"Cell"},{"key":"1694_CR112","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.neuron.2015.05.001","volume":"86","author":"F Fuhrmann","year":"2015","unstructured":"Fuhrmann F, et al. Locomotion, Theta oscillations, and the speed-correlated firing of hippocampal neurons are controlled by a medial septal glutamatergic circuit. Neuron. 2015;86:1253\u201364.","journal-title":"Neuron"},{"key":"1694_CR113","first-page":"3553","volume":"27","author":"B Kolisnyk","year":"2017","unstructured":"Kolisnyk B, et al. Cholinergic surveillance over hippocampal RNA metabolism and Alzheimer\u2019s-like pathology. Cereb Cortex. 2017;27:3553\u201367.","journal-title":"Cereb Cortex"},{"key":"1694_CR114","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cne.903300103","volume":"330","author":"S Leh\u00e9ricy","year":"1993","unstructured":"Leh\u00e9ricy S, et al. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer\u2019s disease. J Comp Neurol. 1993;330:15\u201331.","journal-title":"J Comp Neurol"},{"key":"1694_CR115","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","volume":"77","author":"FSH Al-Shaikh","year":"2020","unstructured":"Al-Shaikh FSH, et al. Selective Vulnerability of the nucleus basalis of meynert among neuropathologic subtypes of Alzheimer disease. JAMA Neurol. 2020;77:225\u201333.","journal-title":"JAMA Neurol"},{"key":"1694_CR116","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","volume":"285","author":"SJ Cohen","year":"2015","unstructured":"Cohen SJ, Stackman RW Jr. Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav Brain Res. 2015;285:105\u201317.","journal-title":"Behav Brain Res"},{"key":"1694_CR117","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuroscience.2024.01.018","volume":"541","author":"J Hashimoto","year":"2024","unstructured":"Hashimoto J, Fujita E, Tanimoto K, Kondo S, Matsumoto-Miyai K. Effects of cardiac glycoside digoxin on dendritic spines and motor learning performance in mice. Neuroscience. 2024;541:77\u201390.","journal-title":"Neuroscience"},{"key":"1694_CR118","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1523\/JNEUROSCI.4272-06.2007","volume":"27","author":"O Lazarov","year":"2007","unstructured":"Lazarov O, et al. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer\u2019s disease-linked mutant presenilin 1. J Neurosci. 2007;27:7011\u201320.","journal-title":"J Neurosci"},{"key":"1694_CR119","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jneumeth.2006.06.001","volume":"158","author":"C Monville","year":"2006","unstructured":"Monville C, Torres EM, Dunnett SB. Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods. 2006;158:219\u201323.","journal-title":"J Neurosci Methods"},{"key":"1694_CR120","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","volume":"189","author":"H Shiotsuki","year":"2010","unstructured":"Shiotsuki H, et al. A rotarod test for evaluation of motor skill learning. J Neurosci Methods. 2010;189:180\u20135.","journal-title":"J Neurosci Methods"},{"key":"1694_CR121","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.nbd.2019.104638","volume":"134","author":"F Yokoi","year":"2019","unstructured":"Yokoi F, et al. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Neurobiol Dis. 2019;134:104638.","journal-title":"Neurobiol Dis"},{"key":"1694_CR122","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2012.05.009","volume":"48","author":"CH Song","year":"2012","unstructured":"Song CH, Fan X, Exeter CJ, Hess EJ, Jinnah HA. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis. 2012;48:66\u201378.","journal-title":"Neurobiol Dis"},{"key":"1694_CR123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbr.2011.10.024","volume":"227","author":"F Yokoi","year":"2012","unstructured":"Yokoi F, et al. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models. Behav Brain Res. 2012;227:12\u201320.","journal-title":"Behav Brain Res"},{"key":"1694_CR124","doi-asserted-by":"publisher","first-page":"957441","DOI":"10.3389\/fncir.2022.957441","volume":"16","author":"JD Kopsick","year":"2022","unstructured":"Kopsick JD, et al. Temporal dynamics of cholinergic activity in the septo-hippocampal system. Front Neural Circuits. 2022;16:957441.","journal-title":"Front Neural Circuits"},{"key":"1694_CR125","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fncel.2017.00091","volume":"11","author":"KS Korshunov","year":"2017","unstructured":"Korshunov KS, Blakemore LJ, Trombley PQ. Dopamine: a modulator of circadian rhythms in the central nervous system. Front Cell Neurosci. 2017;11:91.","journal-title":"Front Cell Neurosci"},{"key":"1694_CR126","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.biopsych.2017.04.018","volume":"84","author":"JWS Timothy","year":"2018","unstructured":"Timothy JWS, et al. Circadian disruptions in the myshkin mouse model of mania are independent of deficits in suprachiasmatic molecular clock function. Biol Psychiatry. 2018;84:827\u201337.","journal-title":"Biol Psychiatry"},{"key":"1694_CR127","doi-asserted-by":"publisher","first-page":"18144","DOI":"10.1073\/pnas.1108416108","volume":"108","author":"GS Kirshenbaum","year":"2011","unstructured":"Kirshenbaum GS, et al. Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+, K+-ATPase alpha3 sodium pump. Proc Natl Acad Sci U S A. 2011;108:18144\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR128","doi-asserted-by":"publisher","first-page":"14085","DOI":"10.1073\/pnas.0904817106","volume":"106","author":"SJ Clapcote","year":"2009","unstructured":"Clapcote SJ, et al. Mutation I810N in the alpha3 isoform of Na+, K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc Natl Acad Sci U S A. 2009;106:14085\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1694_CR129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fnbeh.2014.00188","volume":"8","author":"R Cachope","year":"2014","unstructured":"Cachope R, Cheer JF. Local control of striatal dopamine release. Front Behav Neurosci. 2014;8:188.","journal-title":"Front Behav Neurosci"},{"key":"1694_CR130","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1523\/JNEUROSCI.21-18-07247.2001","volume":"21","author":"L Prensa","year":"2001","unstructured":"Prensa L, Parent A. The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome\/matrix striatal compartments. J Neurosci. 2001;21:7247\u201360.","journal-title":"J Neurosci"},{"key":"1694_CR131","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","volume":"29","author":"W Matsuda","year":"2009","unstructured":"Matsuda W, et al. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009;29:444\u201353.","journal-title":"J Neurosci"},{"key":"1694_CR132","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2016.07.002","volume":"81","author":"N Chuhma","year":"2017","unstructured":"Chuhma N, Mingote S, Kalmbach A, Yetnikoff L, Rayport S. Heterogeneity in dopamine neuron synaptic actions across the striatum and its relevance for schizophrenia. Biol Psychiatry. 2017;81:43\u201351.","journal-title":"Biol Psychiatry"},{"key":"1694_CR133","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ncn3.12670","volume":"11","author":"F Yokoi","year":"2023","unstructured":"Yokoi F. Reconsideration of the firing loop models for dystonia and Parkinson\u2019s disease. Neurol Clin Neurosci. 2023;11:3\u20139.","journal-title":"Neurol Clin Neurosci"},{"key":"1694_CR134","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1020736131907","volume":"22","author":"C Da Cunha","year":"2002","unstructured":"Da Cunha C, Angelucci ME, Canteras NS, Wonnacott S, Takahashi RN. The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson\u2019s disease memory disabilities. Cell Mol Neurobiol. 2002;22:227\u201337.","journal-title":"Cell Mol Neurobiol"},{"key":"1694_CR135","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuroscience.2023.02.002","volume":"515","author":"NS Lee","year":"2023","unstructured":"Lee NS, Kim CY, Beery AK. Peer social environment impacts behavior and dopamine d1 receptor density in prairie voles (Microtus ochrogaster). Neuroscience. 2023;515:62\u201370.","journal-title":"Neuroscience"},{"key":"1694_CR136","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41593-021-00972-9","volume":"25","author":"C Soli\u00e9","year":"2022","unstructured":"Soli\u00e9 C, Girard B, Righetti B, Tapparel M, Bellone C. VTA dopamine neuron activity encodes social interaction and promotes reinforcement learning through social prediction error. Nat Neurosci. 2022;25:86\u201397.","journal-title":"Nat Neurosci"},{"issue":"Pt 6","key":"1694_CR137","first-page":"502","volume":"35","author":"SM Pueschel","year":"1991","unstructured":"Pueschel SM, Bernier JC, Pezzullo JC. Behavioural observations in children with Down\u2019s syndrome. J Ment Defic Res. 1991;35(Pt 6):502\u201311.","journal-title":"J Ment Defic Res"},{"key":"1694_CR138","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","volume":"41","author":"O Benek","year":"2020","unstructured":"Benek O, Korabecny J, Soukup O. A perspective on multi-target drugs for Alzheimer\u2019s disease. Trends Pharmacol Sci. 2020;41:434\u201345.","journal-title":"Trends Pharmacol Sci"},{"key":"1694_CR139","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review. JAMA. 2020;323:548\u201360.","journal-title":"JAMA"},{"key":"1694_CR140","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"1694_CR141","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1523\/JNEUROSCI.12-11-04391.1992","volume":"12","author":"B Kn\u00fcsel","year":"1992","unstructured":"Kn\u00fcsel B, et al. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci. 1992;12:4391\u2013402.","journal-title":"J Neurosci"},{"key":"1694_CR142","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/cpt.1548","volume":"106","author":"DA Monti","year":"2019","unstructured":"Monti DA, et al. N-Acetyl cysteine is associated with dopaminergic improvement in Parkinson\u2019s disease. Clin Pharmacol Ther. 2019;106:884\u201390.","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 2","key":"1694_CR143","first-page":"S656","volume":"24","author":"C Gaig","year":"2009","unstructured":"Gaig C, Tolosa E. When does Parkinson\u2019s disease begin? Mov Disord. 2009;24(Suppl 2):S656-664.","journal-title":"Mov Disord"},{"key":"1694_CR144","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2147\/NDT.S170281","volume":"14","author":"C Hidaka","year":"2018","unstructured":"Hidaka C, Kashio T, Uchigaki D, Mitsui S. Vulnerability or resilience of motopsin knockout mice to maternal separation stress depending on adulthood behaviors. Neuropsychiatr Dis Treat. 2018;14:2255\u201368.","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01694-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01694-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01694-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:04:52Z","timestamp":1773050692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01694-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01694-7","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}